Peroxiredoxin 4 antibody (full length)
Quick Overview for Peroxiredoxin 4 antibody (full length) (ABIN7878791)
Target
See all Peroxiredoxin 4 (PRDX4) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
Clone
-
-
Binding Specificity
- full length
-
Purpose
- Peroxiredoxin 4 Antibody / PRDX4 (azide and preservative free)
-
Purification
- Protein G affinity
-
Immunogen
- A recombinant full-length human PRDX4 protein was used as the immunogen for the Peroxiredoxin 4 antibody.
-
Isotype
- IgG2a, kappa
-
-
-
-
Application Notes
- Optimal dilution of the Peroxiredoxin 4 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Aliquot the Peroxiredoxin 4 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- Peroxiredoxin 4 (PRDX4)
-
Alternative Name
- Peroxiredoxin 4
-
Background
- The peroxiredoxin (PRX) family comprises six antioxidant proteins, PRX I, II, III, IV, V and VI, which protect cells from reactive oxygen species (ROS) by preventing the metal-catalyzed oxidation of enzymes. The PRX proteins primarily utilize thioredoxin as the electron donor for antioxidation, although they are fairly promiscuous with regard to the hydroperoxide substrate. In addition to protection from ROS, peroxiredoxins are also involved in cell proliferation, differentiation and gene expression. PRX I, II, IV and VI show diffuse cytoplasmic localization, while PRX III and V exhibit distinct mitochondrial localization. The human PRX IV gene is expressed in many tissues. It exists as a precursor protein, which is only detected in testis, and aprocessed secreted form. PRX IV is highly expressed in lung cancer and is necessary for the promotion of lung cancer in vitro. Studies have demonstrated that PRX IV positive expression is significantly correlated with recurrences and shorter disease-free survival in patients with early-stage lung squamous cell carcinoma, and therefore can be used as a prognostic marker in lung squamous cell carcinoma.
-
UniProt
- Q13162
Target
-